Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective

Program Description
Atopic dermatitis (AD) is a commonly occurring inflammatory skin condition that causes patients to experience redness and itching. As frontline health care providers, pharmacists and pharmacy technicians are likely to encounter patients seeking information about OTC skin care products for AD. Routine use of daily moisturizers and adjunctive therapies has shown to improve the skin barrier and reduce symptoms associated with AD; however, several barriers to the optimal use of these products exist that limit patient adherence and outcomes. This podcast will review counseling points about the proper use of OTC skin care products for AD treatment and management as well as strategies for pharmacists and pharmacy technicians to identify and address barriers affecting adherence. The discussion will also feature the perspective of a caregiver of a patient living with AD who will provide additional insight into challenges faced with AD treatment.

Target Audience: Retail pharmacists and pharmacy technicians

Type of Activity: Knowledge
Release date: June 30, 2023
Expiration date: July 24, 2025

Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Review patient barriers that impact optimal treatment of patients with atopic dermatitis (AD) who are seeking OTC care
• List strategies to individualize patient care and improve recommendations for AD

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity numbers 0290-0000-23-268-H01-P and 0290-0000-23-268-H01-T. The activity is available for CE credit through July 24, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, complete the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Mary Bridgeman, PharmD, BCPS, BCGP, has no financial relationships with commercial interests to disclose.

Ashley Ellis, PharmD, MBA, CDECS, has the following financial relationships with commercial interests to disclose:

Grant/Research Support: Researcher AHRQ “Tennessee Heart Health Network” funding in form of salary release dollars

Consultant: Global Parents for Eczema Research, Continuing Education Alliance, McGraw Hill

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms